Cargando…
“Teaching old drugs to kill new bugs”: structure-based discovery of anti-SARS drugs
Severe acute respiratory syndrome (SARS) main protease or 3C-like protease (3CLpro) is essential for the propagation of the coronaviral life cycle and is regarded as one of the main targets for structure-based anti-SARS drug design. It is an attractive approach to find new uses for old drugs as they...
Autores principales: | Rajnarayanan, Rajendram V., Dakshanamurthy, Sivanesan, Pattabiraman, Nagarajan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Inc.
2004
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7092804/ https://www.ncbi.nlm.nih.gov/pubmed/15358186 http://dx.doi.org/10.1016/j.bbrc.2004.06.155 |
Ejemplares similares
-
ES-Screen: A Novel Electrostatics-Driven Method for Drug Discovery Virtual Screening
por: Issa, Naiem T., et al.
Publicado: (2022) -
A New Hybrid Neural Network Deep Learning Method for Protein–Ligand Binding Affinity Prediction and De Novo Drug Design
por: Limbu, Sarita, et al.
Publicado: (2022) -
Bugs & drugs
Publicado: (2019) -
DrugGenEx-Net: a novel computational platform for systems pharmacology and gene expression-based drug repurposing
por: Issa, Naiem T., et al.
Publicado: (2016) -
Immune characterization and profiles of SARS-CoV-2 infected patients reveals potential host therapeutic targets and SARS-CoV-2 oncogenesis mechanism
por: Policard, Martine, et al.
Publicado: (2021)